Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Therapy in Hip Replacement
NCT05722301Phase 3Withdrawn
- Sponsor
- American Hip Institute
- Start
- Nov 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of testosterone in testosterone deficiency (TD) (2 arms), sponsored by American Hip Institute. Primary endpoints: Harris Hip Score at 1 year and Forgotten Joint Score at 1 year. Planned start Nov 2019; status: withdrawn.
02
Drugs
testosterone
03
Conditions
testosterone deficiency (TD)
Beyond the preview
Go deeper on NCT05722301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05722301.